NewsBenzingaGSK、2026会計年度の調整後1株当たり利益見通しを4.90～5.00ドルと再確認、予想4.78ドルを上回る 2026会計年度の売上高見通しも447.54億ドルと再確認、予想451.50億ドルを下回る GSK、2026会計年度の調整後1株当たり利益見通しを4.90～5.00ドルと再確認、予想4.78ドルを上回る 2026会計年度の売上高見通しも447.54億ドルと再確認、予想451.50億ドルを下回る Benzinga 2026.10.28 07:58 (GMT+0) Open on Benzinga Other news Coinbase Customer Data Hit in Analytics Vendor Breach, Funds ‘Not Impacted’ Gentex: A Resilient Cash Generator In A Troubled Automotive Market (NASDAQ:GNTX) F5, Inc. 2026 Q4 - Results - Earnings Call Presentation (NASDAQ:FFIV) 2026-10-28 Ares Capital: Double-Digit Yield, A Huge Acquisition, And A Major Warning (NASDAQ:ARCC) MercadoLibre Stock: Brazil Panicked, I’m Buying (NASDAQ:MELI) BXP: Occupancy Momentum Can Support Shares (NYSE:BXP)
